1967
DOI: 10.1016/s0022-5347(17)63070-2
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Bilateral Adrenalectomy on Induced Benign Prostatic Hyperplasia in Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

1971
1971
1991
1991

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 5 publications
0
5
0
Order By: Relevance
“…Comparison of the 3-and 6-month assessments suggested that a longer period of treatment was unlikely to be more effective. Fingerhut and Veenema (1968) used a similar dose in their studies and found improvement after 6 weeks of treatment.…”
Section: Discussionmentioning
confidence: 96%
See 1 more Smart Citation
“…Comparison of the 3-and 6-month assessments suggested that a longer period of treatment was unlikely to be more effective. Fingerhut and Veenema (1968) used a similar dose in their studies and found improvement after 6 weeks of treatment.…”
Section: Discussionmentioning
confidence: 96%
“…Spironolactone may be useful in the treatment of benign prostatic hypertrophy (Fingerhut and Veenema, 1967), and uncontrolled clinical studies suggest that it is useful in 60-65 per cent of patients (Fingerhut and Veenema, 1968).…”
mentioning
confidence: 99%
“…Although dog and man develop similar in the elderly age benign prostatic enlargement, they are different by means of clinical and histological differentia tion (5,10). Similar reservations apply to studies on rodents where attempts have been made to produce BPH by administration of estrogens and various metabolites of testos terone (8). Considerable interest has been generated recently by De Klerk et al (7) that benign prostatic enlargement can be induced in the dog by long-term administration of 5a-dihydrotestosterone, 5a-androstane-3a-l7/3-diol in intact animals and of 5a-dihydrotestosterone, 5a-androstane-3a-l 7/3-diol in combination with 17/3-estradiol in castrated animals.…”
Section: Introductionmentioning
confidence: 98%
“…Recently a new compound, estramustine phosphate (Estracyt)2 has been tested and may be efficacious in advanced disease [95][96][97][98]. Various surgical ablation proce dures to reduce androgen levels have been tested [99][100][101]. Analysis of DNA and RNA polymerase, as keys to rates of cell metabolism and protein synthesis, and degradation patterns of administered hormones have been done to elucidate the role of hormones in prostatic activity [102][103][104][105][106], An extensive review and discussion of new data indicating that cyproterone can block specific DNA synthesis during the Gi phase was presented [107].…”
Section: Hormonal Studiesmentioning
confidence: 99%